NGNE
Neurogene (NGNE)
$53
About Neurogene (NGNE)
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
Details
Daily high
$21.10
Daily low
$19.51
Price at open
$20.33
52 Week High
$37.27
52 Week Low
$6.88
Market cap
302.5M
Dividend yield
0.00%
Volume
289,614
Avg. volume
193,400
P/E ratio
-4.41
Neurogene News
Details
Daily high
$21.10
Daily low
$19.51
Price at open
$20.33
52 Week High
$37.27
52 Week Low
$6.88
Market cap
302.5M
Dividend yield
0.00%
Volume
289,614
Avg. volume
193,400
P/E ratio
-4.41